What is the recommended dosage and administration of ceftriaxone (Ceftriaxone) for pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ceftriaxone Dosing in Pediatric Patients

For pediatric patients, ceftriaxone should be administered at 50-75 mg/kg/day once daily or divided every 12-24 hours for most infections, with dosage adjustments based on infection severity, site, and patient age. 1, 2

Age-Specific Dosing

  • For neonates ≤7 days of age: 50 mg/kg/day given every 24 hours 1
  • For neonates >7 days and ≤2000 g: 50 mg/kg/day given every 24 hours 1
  • For neonates >7 days and >2000 g: 50-75 mg/kg/day given every 24 hours 1
  • Ceftriaxone should not be used in hyperbilirubinemic neonates due to risk of bilirubin encephalopathy 1, 2

Indication-Specific Dosing

Meningitis

  • 100 mg/kg/day divided every 12-24 hours (maximum 4 g daily) 1, 2
  • Intravenous administration over 60 minutes in neonates to reduce risk of bilirubin encephalopathy 2
  • Duration of therapy typically 7-14 days 2, 3

Respiratory Infections

  • For pneumonia: 50-100 mg/kg/day once daily or divided every 12-24 hours 1, 4
  • For pneumococcal pneumonia with penicillin resistance: 100 mg/kg/day given every 12-24 hours 1, 5

Skin and Soft Tissue Infections

  • 50-75 mg/kg/day once daily (or divided twice daily) 2, 6
  • Maximum total daily dose: 2 grams 2

Otitis Media

  • Single intramuscular dose of 50 mg/kg (not to exceed 1 gram) 2

Other Serious Infections

  • For bacteremia or arthritis: 50 mg/kg/day given daily for 7 days 1
  • For complicated intra-abdominal infections and sepsis: 50-75 mg/kg/day given every 12-24 hours 1
  • For gonococcal conjunctivitis in children ≤45 kg: 25-50 mg/kg IV or IM as a single dose (maximum 250 mg) 1

Pathogen-Specific Considerations

  • For gram-negative enteric bacilli: 100 mg/kg/day divided every 12 hours or 80 mg/kg/day every 24 hours (maximum 4 g daily) 1
  • For Streptococcus pneumoniae with penicillin MIC <2.0 μg/mL: 50-100 mg/kg/day every 12-24 hours 5
  • For penicillin-resistant Streptococcus pneumoniae (MIC ≥4.0 μg/mL): 100 mg/kg/day every 12-24 hours 5
  • For Haemophilus influenzae (β-lactamase producing): 50-100 mg/kg/day every 12-24 hours 5, 7

Administration Guidelines

  • Intravenous doses should be administered over 30 minutes in pediatric patients 2
  • In neonates, administer over 60 minutes to reduce risk of bilirubin encephalopathy 2
  • For IV administration, reconstitute to concentrations between 10-40 mg/mL 2
  • Do not use diluents containing calcium (e.g., Ringer's solution) due to risk of particulate formation 2

Clinical Efficacy and Safety

  • Once-daily administration (50-80 mg/kg) has demonstrated 94-96% clinical cure rates in serious pediatric infections 7, 6
  • Bacteriologic cure rates of 90-98% have been reported with once-daily dosing 7, 3, 8
  • Common side effects include gastrointestinal symptoms and transient neutropenia 6

Important Considerations

  • Duration of therapy typically ranges from 4-14 days depending on infection type and severity 2
  • For Streptococcus pyogenes infections, treatment should continue for at least 10 days 2
  • Once-daily dosing provides similar efficacy to divided doses with greater convenience 4, 6
  • No dosage adjustment is necessary for patients with renal or hepatic impairment unless severe 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.